KPRX
KPRX
NASDAQ · Pharmaceuticals

Kiora Pharmaceuticals Inc

$2.48
+0.03 (+1.22%)
As of May 9, 2:24 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,083.1% upside
Low Target $16.75
Average Target $29.34
High Target $32.13
Current Price $2.48
Current
$2.48
Target
$29.34
$16.75 $29.34 avg $32.13
Scenario Analysis
Bear Case
$16.75
575.4%
Low target
Base Case
$29.34
+1,083.1%
Avg target
Bull Case
$32.13
+1,195.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.18
-40.7% from high
52-Week Low
$1.76
+40.5% from low
Target vs 52W High
$29.34
+601.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%